Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Cell and Gene Therapy Manufacturing QC Market Growth (Status and Outlook) 2022-2028

  • LP 4884890
  • 110 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Cell and Gene Therapy Manufacturing QC will have significant change from previous year. According to our (LP Information) latest study, the global Cell and Gene Therapy Manufacturing QC market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cell and Gene Therapy Manufacturing QC market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Cell and Gene Therapy Manufacturing QC market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cell and Gene Therapy Manufacturing QC market, reaching US$ million by the year 2028. As for the Europe Cell and Gene Therapy Manufacturing QC landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Cell and Gene Therapy Manufacturing QC players cover Bio-Techne Corporation, BioMerieux SA, Catalent, Inc., and Charles River Laboratories International Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy Manufacturing QC market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Safety Testing

Purity Testing

Potency Testing

Identity Testing

Stability Testing

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Precision Therapy

Biological Research

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Bio-Techne Corporation

BioMerieux SA

Catalent, Inc.

Charles River Laboratories International Inc.

Eurofins Scientific SE

F. Hoffmann-La Roche Ltd

Intertek Group plc

Lonza Group AG

Merck KGaA

Sartorius AG

SGS S.A.

Sistemic Scotland Limited

Thermo Fisher Scientific Inc.

Vigene Biosciences, Inc.

WuXi AppTec

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cell and Gene Therapy Manufacturing QC Market Size 2017-2028

2.1.2 Cell and Gene Therapy Manufacturing QC Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Cell and Gene Therapy Manufacturing QC Segment by Type

2.2.1 Safety Testing

2.2.2 Purity Testing

2.2.3 Potency Testing

2.2.4 Identity Testing

2.2.5 Stability Testing

2.3 Cell and Gene Therapy Manufacturing QC Market Size by Type

2.3.1 Cell and Gene Therapy Manufacturing QC Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Cell and Gene Therapy Manufacturing QC Market Size Market Share by Type (2017-2022)

2.4 Cell and Gene Therapy Manufacturing QC Segment by Application

2.4.1 Precision Therapy

2.4.2 Biological Research

2.5 Cell and Gene Therapy Manufacturing QC Market Size by Application

2.5.1 Cell and Gene Therapy Manufacturing QC Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application (2017-2022)

3 Cell and Gene Therapy Manufacturing QC Market Size by Player

3.1 Cell and Gene Therapy Manufacturing QC Market Size Market Share by Players

3.1.1 Global Cell and Gene Therapy Manufacturing QC Revenue by Players (2020-2022)

3.1.2 Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Players (2020-2022)

3.2 Global Cell and Gene Therapy Manufacturing QC Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Cell and Gene Therapy Manufacturing QC by Regions

4.1 Cell and Gene Therapy Manufacturing QC Market Size by Regions (2017-2022)

4.2 Americas Cell and Gene Therapy Manufacturing QC Market Size Growth (2017-2022)

4.3 APAC Cell and Gene Therapy Manufacturing QC Market Size Growth (2017-2022)

4.4 Europe Cell and Gene Therapy Manufacturing QC Market Size Growth (2017-2022)

4.5 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size Growth (2017-2022)

5 Americas

5.1 Americas Cell and Gene Therapy Manufacturing QC Market Size by Country (2017-2022)

5.2 Americas Cell and Gene Therapy Manufacturing QC Market Size by Type (2017-2022)

5.3 Americas Cell and Gene Therapy Manufacturing QC Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cell and Gene Therapy Manufacturing QC Market Size by Region (2017-2022)

6.2 APAC Cell and Gene Therapy Manufacturing QC Market Size by Type (2017-2022)

6.3 APAC Cell and Gene Therapy Manufacturing QC Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Cell and Gene Therapy Manufacturing QC by Country (2017-2022)

7.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2017-2022)

7.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC by Region (2017-2022)

8.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2017-2022)

8.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Cell and Gene Therapy Manufacturing QC Market Forecast

10.1 Global Cell and Gene Therapy Manufacturing QC Forecast by Regions (2023-2028)

10.1.1 Global Cell and Gene Therapy Manufacturing QC Forecast by Regions (2023-2028)

10.1.2 Americas Cell and Gene Therapy Manufacturing QC Forecast

10.1.3 APAC Cell and Gene Therapy Manufacturing QC Forecast

10.1.4 Europe Cell and Gene Therapy Manufacturing QC Forecast

10.1.5 Middle East & Africa Cell and Gene Therapy Manufacturing QC Forecast

10.2 Americas Cell and Gene Therapy Manufacturing QC Forecast by Country (2023-2028)

10.2.1 United States Cell and Gene Therapy Manufacturing QC Market Forecast

10.2.2 Canada Cell and Gene Therapy Manufacturing QC Market Forecast

10.2.3 Mexico Cell and Gene Therapy Manufacturing QC Market Forecast

10.2.4 Brazil Cell and Gene Therapy Manufacturing QC Market Forecast

10.3 APAC Cell and Gene Therapy Manufacturing QC Forecast by Region (2023-2028)

10.3.1 China Cell and Gene Therapy Manufacturing QC Market Forecast

10.3.2 Japan Cell and Gene Therapy Manufacturing QC Market Forecast

10.3.3 Korea Cell and Gene Therapy Manufacturing QC Market Forecast

10.3.4 Southeast Asia Cell and Gene Therapy Manufacturing QC Market Forecast

10.3.5 India Cell and Gene Therapy Manufacturing QC Market Forecast

10.3.6 Australia Cell and Gene Therapy Manufacturing QC Market Forecast

10.4 Europe Cell and Gene Therapy Manufacturing QC Forecast by Country (2023-2028)

10.4.1 Germany Cell and Gene Therapy Manufacturing QC Market Forecast

10.4.2 France Cell and Gene Therapy Manufacturing QC Market Forecast

10.4.3 UK Cell and Gene Therapy Manufacturing QC Market Forecast

10.4.4 Italy Cell and Gene Therapy Manufacturing QC Market Forecast

10.4.5 Russia Cell and Gene Therapy Manufacturing QC Market Forecast

10.5 Middle East & Africa Cell and Gene Therapy Manufacturing QC Forecast by Region (2023-2028)

10.5.1 Egypt Cell and Gene Therapy Manufacturing QC Market Forecast

10.5.2 South Africa Cell and Gene Therapy Manufacturing QC Market Forecast

10.5.3 Israel Cell and Gene Therapy Manufacturing QC Market Forecast

10.5.4 Turkey Cell and Gene Therapy Manufacturing QC Market Forecast

10.5.5 GCC Countries Cell and Gene Therapy Manufacturing QC Market Forecast

10.6 Global Cell and Gene Therapy Manufacturing QC Forecast by Type (2023-2028)

10.7 Global Cell and Gene Therapy Manufacturing QC Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Bio-Techne Corporation

11.1.1 Bio-Techne Corporation Company Information

11.1.2 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Product Offered

11.1.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Bio-Techne Corporation Main Business Overview

11.1.5 Bio-Techne Corporation Latest Developments

11.2 BioMerieux SA

11.2.1 BioMerieux SA Company Information

11.2.2 BioMerieux SA Cell and Gene Therapy Manufacturing QC Product Offered

11.2.3 BioMerieux SA Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 BioMerieux SA Main Business Overview

11.2.5 BioMerieux SA Latest Developments

11.3 Catalent, Inc.

11.3.1 Catalent, Inc. Company Information

11.3.2 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Product Offered

11.3.3 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Catalent, Inc. Main Business Overview

11.3.5 Catalent, Inc. Latest Developments

11.4 Charles River Laboratories International Inc.

11.4.1 Charles River Laboratories International Inc. Company Information

11.4.2 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Product Offered

11.4.3 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Charles River Laboratories International Inc. Main Business Overview

11.4.5 Charles River Laboratories International Inc. Latest Developments

11.5 Eurofins Scientific SE

11.5.1 Eurofins Scientific SE Company Information

11.5.2 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Product Offered

11.5.3 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Eurofins Scientific SE Main Business Overview

11.5.5 Eurofins Scientific SE Latest Developments

11.6 F. Hoffmann-La Roche Ltd

11.6.1 F. Hoffmann-La Roche Ltd Company Information

11.6.2 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Product Offered

11.6.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 F. Hoffmann-La Roche Ltd Main Business Overview

11.6.5 F. Hoffmann-La Roche Ltd Latest Developments

11.7 Intertek Group plc

11.7.1 Intertek Group plc Company Information

11.7.2 Intertek Group plc Cell and Gene Therapy Manufacturing QC Product Offered

11.7.3 Intertek Group plc Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Intertek Group plc Main Business Overview

11.7.5 Intertek Group plc Latest Developments

11.8 Lonza Group AG

11.8.1 Lonza Group AG Company Information

11.8.2 Lonza Group AG Cell and Gene Therapy Manufacturing QC Product Offered

11.8.3 Lonza Group AG Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Lonza Group AG Main Business Overview

11.8.5 Lonza Group AG Latest Developments

11.9 Merck KGaA

11.9.1 Merck KGaA Company Information

11.9.2 Merck KGaA Cell and Gene Therapy Manufacturing QC Product Offered

11.9.3 Merck KGaA Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Merck KGaA Main Business Overview

11.9.5 Merck KGaA Latest Developments

11.10 Sartorius AG

11.10.1 Sartorius AG Company Information

11.10.2 Sartorius AG Cell and Gene Therapy Manufacturing QC Product Offered

11.10.3 Sartorius AG Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Sartorius AG Main Business Overview

11.10.5 Sartorius AG Latest Developments

11.11 SGS S.A.

11.11.1 SGS S.A. Company Information

11.11.2 SGS S.A. Cell and Gene Therapy Manufacturing QC Product Offered

11.11.3 SGS S.A. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 SGS S.A. Main Business Overview

11.11.5 SGS S.A. Latest Developments

11.12 Sistemic Scotland Limited

11.12.1 Sistemic Scotland Limited Company Information

11.12.2 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Product Offered

11.12.3 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Sistemic Scotland Limited Main Business Overview

11.12.5 Sistemic Scotland Limited Latest Developments

11.13 Thermo Fisher Scientific Inc.

11.13.1 Thermo Fisher Scientific Inc. Company Information

11.13.2 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Product Offered

11.13.3 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Thermo Fisher Scientific Inc. Main Business Overview

11.13.5 Thermo Fisher Scientific Inc. Latest Developments

11.14 Vigene Biosciences, Inc.

11.14.1 Vigene Biosciences, Inc. Company Information

11.14.2 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Product Offered

11.14.3 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Vigene Biosciences, Inc. Main Business Overview

11.14.5 Vigene Biosciences, Inc. Latest Developments

11.15 WuXi AppTec

11.15.1 WuXi AppTec Company Information

11.15.2 WuXi AppTec Cell and Gene Therapy Manufacturing QC Product Offered

11.15.3 WuXi AppTec Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 WuXi AppTec Main Business Overview

11.15.5 WuXi AppTec Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Cell and Gene Therapy Manufacturing QC Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Safety Testing

Table 3. Major Players of Purity Testing

Table 4. Major Players of Potency Testing

Table 5. Major Players of Identity Testing

Table 6. Major Players of Stability Testing

Table 7. Cell and Gene Therapy Manufacturing QC Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Cell and Gene Therapy Manufacturing QC Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Cell and Gene Therapy Manufacturing QC Market Size Market Share by Type (2017-2022)

Table 10. Cell and Gene Therapy Manufacturing QC Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Cell and Gene Therapy Manufacturing QC Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application (2017-2022)

Table 13. Global Cell and Gene Therapy Manufacturing QC Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Player (2020-2022)

Table 15. Cell and Gene Therapy Manufacturing QC Key Players Head office and Products Offered

Table 16. Cell and Gene Therapy Manufacturing QC Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Cell and Gene Therapy Manufacturing QC Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Cell and Gene Therapy Manufacturing QC Market Size Market Share by Regions (2017-2022)

Table 21. Americas Cell and Gene Therapy Manufacturing QC Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Cell and Gene Therapy Manufacturing QC Market Size Market Share by Country (2017-2022)

Table 23. Americas Cell and Gene Therapy Manufacturing QC Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Cell and Gene Therapy Manufacturing QC Market Size Market Share by Type (2017-2022)

Table 25. Americas Cell and Gene Therapy Manufacturing QC Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application (2017-2022)

Table 27. APAC Cell and Gene Therapy Manufacturing QC Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Cell and Gene Therapy Manufacturing QC Market Size Market Share by Region (2017-2022)

Table 29. APAC Cell and Gene Therapy Manufacturing QC Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Cell and Gene Therapy Manufacturing QC Market Size Market Share by Type (2017-2022)

Table 31. APAC Cell and Gene Therapy Manufacturing QC Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application (2017-2022)

Table 33. Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Cell and Gene Therapy Manufacturing QC Market Size Market Share by Country (2017-2022)

Table 35. Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Cell and Gene Therapy Manufacturing QC Market Size Market Share by Type (2017-2022)

Table 37. Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Cell and Gene Therapy Manufacturing QC

Table 46. Key Market Challenges & Risks of Cell and Gene Therapy Manufacturing QC

Table 47. Key Industry Trends of Cell and Gene Therapy Manufacturing QC

Table 48. Global Cell and Gene Therapy Manufacturing QC Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Cell and Gene Therapy Manufacturing QC Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Cell and Gene Therapy Manufacturing QC Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Cell and Gene Therapy Manufacturing QC Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Cell and Gene Therapy Manufacturing QC Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Cell and Gene Therapy Manufacturing QC Market Size Market Share Forecast by Application (2023-2028)

Table 54. Bio-Techne Corporation Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors

Table 55. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Product Offered

Table 56. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Bio-Techne Corporation Main Business

Table 58. Bio-Techne Corporation Latest Developments

Table 59. BioMerieux SA Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors

Table 60. BioMerieux SA Cell and Gene Therapy Manufacturing QC Product Offered

Table 61. BioMerieux SA Main Business

Table 62. BioMerieux SA Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. BioMerieux SA Latest Developments

Table 64. Catalent, Inc. Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors

Table 65. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Product Offered

Table 66. Catalent, Inc. Main Business

Table 67. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Catalent, Inc. Latest Developments

Table 69. Charles River Laboratories International Inc. Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors

Table 70. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Product Offered

Table 71. Charles River Laboratories International Inc. Main Business

Table 72. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Charles River Laboratories International Inc. Latest Developments

Table 74. Eurofins Scientific SE Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors

Table 75. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Product Offered

Table 76. Eurofins Scientific SE Main Business

Table 77. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Eurofins Scientific SE Latest Developments

Table 79. F. Hoffmann-La Roche Ltd Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors

Table 80. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Product Offered

Table 81. F. Hoffmann-La Roche Ltd Main Business

Table 82. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. F. Hoffmann-La Roche Ltd Latest Developments

Table 84. Intertek Group plc Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors

Table 85. Intertek Group plc Cell and Gene Therapy Manufacturing QC Product Offered

Table 86. Intertek Group plc Main Business

Table 87. Intertek Group plc Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. Intertek Group plc Latest Developments

Table 89. Lonza Group AG Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors

Table 90. Lonza Group AG Cell and Gene Therapy Manufacturing QC Product Offered

Table 91. Lonza Group AG Main Business

Table 92. Lonza Group AG Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Lonza Group AG Latest Developments

Table 94. Merck KGaA Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors

Table 95. Merck KGaA Cell and Gene Therapy Manufacturing QC Product Offered

Table 96. Merck KGaA Main Business

Table 97. Merck KGaA Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 98. Merck KGaA Latest Developments

Table 99. Sartorius AG Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors

Table 100. Sartorius AG Cell and Gene Therapy Manufacturing QC Product Offered

Table 101. Sartorius AG Main Business

Table 102. Sartorius AG Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 103. Sartorius AG Latest Developments

Table 104. SGS S.A. Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors

Table 105. SGS S.A. Cell and Gene Therapy Manufacturing QC Product Offered

Table 106. SGS S.A. Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 107. SGS S.A. Main Business

Table 108. SGS S.A. Latest Developments

Table 109. Sistemic Scotland Limited Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors

Table 110. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Product Offered

Table 111. Sistemic Scotland Limited Main Business

Table 112. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 113. Sistemic Scotland Limited Latest Developments

Table 114. Thermo Fisher Scientific Inc. Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors

Table 115. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Product Offered

Table 116. Thermo Fisher Scientific Inc. Main Business

Table 117. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 118. Thermo Fisher Scientific Inc. Latest Developments

Table 119. Vigene Biosciences, Inc. Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors

Table 120. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Product Offered

Table 121. Vigene Biosciences, Inc. Main Business

Table 122. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 123. Vigene Biosciences, Inc. Latest Developments

Table 124. WuXi AppTec Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors

Table 125. WuXi AppTec Cell and Gene Therapy Manufacturing QC Product Offered

Table 126. WuXi AppTec Main Business

Table 127. WuXi AppTec Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 128. WuXi AppTec Latest Developments

List of Figures

Figure 1. Cell and Gene Therapy Manufacturing QC Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Cell and Gene Therapy Manufacturing QC Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Cell and Gene Therapy Manufacturing QC Market Size Market Share by Type in 2021

Figure 7. Cell and Gene Therapy Manufacturing QC in Precision Therapy

Figure 8. Global Cell and Gene Therapy Manufacturing QC Market: Precision Therapy (2017-2022) & ($ Millions)

Figure 9. Cell and Gene Therapy Manufacturing QC in Biological Research

Figure 10. Global Cell and Gene Therapy Manufacturing QC Market: Biological Research (2017-2022) & ($ Millions)

Figure 11. Global Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application in 2021

Figure 12. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Player in 2021

Figure 13. Global Cell and Gene Therapy Manufacturing QC Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Cell and Gene Therapy Manufacturing QC Market Size 2017-2022 ($ Millions)

Figure 15. APAC Cell and Gene Therapy Manufacturing QC Market Size 2017-2022 ($ Millions)

Figure 16. Europe Cell and Gene Therapy Manufacturing QC Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size 2017-2022 ($ Millions)

Figure 18. Americas Cell and Gene Therapy Manufacturing QC Value Market Share by Country in 2021

Figure 19. Americas Cell and Gene Therapy Manufacturing QC Consumption Market Share by Type in 2021

Figure 20. Americas Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application in 2021

Figure 21. United States Cell and Gene Therapy Manufacturing QC Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Cell and Gene Therapy Manufacturing QC Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Cell and Gene Therapy Manufacturing QC Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Cell and Gene Therapy Manufacturing QC Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Cell and Gene Therapy Manufacturing QC Market Size Market Share by Region in 2021

Figure 26. APAC Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application in 2021

Figure 27. China Cell and Gene Therapy Manufacturing QC Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Cell and Gene Therapy Manufacturing QC Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Cell and Gene Therapy Manufacturing QC Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Cell and Gene Therapy Manufacturing QC Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Cell and Gene Therapy Manufacturing QC Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Cell and Gene Therapy Manufacturing QC Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Cell and Gene Therapy Manufacturing QC Market Size Market Share by Country in 2021

Figure 34. Europe Cell and Gene Therapy Manufacturing QC Market Size Market Share by Type in 2021

Figure 35. Europe Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application in 2021

Figure 36. Germany Cell and Gene Therapy Manufacturing QC Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Cell and Gene Therapy Manufacturing QC Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Cell and Gene Therapy Manufacturing QC Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Cell and Gene Therapy Manufacturing QC Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Cell and Gene Therapy Manufacturing QC Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application in 2021

Figure 44. Egypt Cell and Gene Therapy Manufacturing QC Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Cell and Gene Therapy Manufacturing QC Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Cell and Gene Therapy Manufacturing QC Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Cell and Gene Therapy Manufacturing QC Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Cell and Gene Therapy Manufacturing QC Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 50. APAC Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 51. Europe Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 53. United States Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 54. Canada Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 57. China Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 58. Japan Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 59. Korea Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 61. India Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 62. Australia Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 63. Germany Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 64. France Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 65. UK Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 66. Italy Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 67. Russia Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 68. Spain Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 71. Israel Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Cell and Gene Therapy Manufacturing QC Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450